Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis

PURPOSE: Although inhibitors of vascular endothelial growth factor and inhibitors of epidermal growth factor receptor (EGFRi) are commonly used for the treatment of metastatic colorectal cancer (mCRC), the optimal sequencing of these agents is currently unclear. METHODS: A national registry of targe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Manag Res
Main Authors: Buchler, Tomas, Chloupkova, Renata, Poprach, Alexandr, Fiala, Ondrej, Kiss, Igor, Kopeckova, Katerina, Dusek, Ladislav, Veskrnova, Veronika, Slavicek, Lubomir, Kohoutek, Milan, Finek, Jindrich, Svoboda, Marek, Petruzelka, Lubos, Melichar, Bohuslav
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6314050/
https://ncbi.nlm.nih.gov/pubmed/30643461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S183093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados